- Home
- BMRA vs PMCB Comparison
BMRA vs PMCB Comparison
Compare BMRA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- PMCB
- Stock Information
- Founded
- BMRA 1971
- PMCB 1996
- Country
- BMRA United States
- PMCB United States
- Employees
- BMRA N/A
- PMCB N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMRA Health Care
- PMCB Health Care
- Exchange
- BMRA Nasdaq
- PMCB Nasdaq
- Market Cap
- BMRA 11.2M
- PMCB 11.4M
- IPO Year
- BMRA N/A
- PMCB N/A
- Fundamental
- Price
- BMRA $3.54
- PMCB $1.21
- Analyst Decision
- BMRA
- PMCB
- Analyst Count
- BMRA 0
- PMCB 0
- Target Price
- BMRA N/A
- PMCB N/A
- AVG Volume (30 Days)
- BMRA 43.6K
- PMCB 17.0K
- Earning Date
- BMRA 04-14-2025
- PMCB 03-17-2025
- Dividend Yield
- BMRA N/A
- PMCB N/A
- EPS Growth
- BMRA N/A
- PMCB N/A
- EPS
- BMRA N/A
- PMCB 1.29
- Revenue
- BMRA $5,678,000.00
- PMCB N/A
- Revenue This Year
- BMRA N/A
- PMCB N/A
- Revenue Next Year
- BMRA N/A
- PMCB N/A
- P/E Ratio
- BMRA N/A
- PMCB $0.88
- Revenue Growth
- BMRA 5.01
- PMCB N/A
- 52 Week Low
- BMRA $1.92
- PMCB $1.03
- 52 Week High
- BMRA $10.16
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- BMRA 39.79
- PMCB 45.37
- Support Level
- BMRA $3.18
- PMCB $1.11
- Resistance Level
- BMRA $3.93
- PMCB $1.27
- Average True Range (ATR)
- BMRA 0.47
- PMCB 0.11
- MACD
- BMRA -0.05
- PMCB 0.01
- Stochastic Oscillator
- BMRA 20.00
- PMCB 71.19
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.